T.-S. Yang

695 total citations
12 papers, 543 citations indexed

About

T.-S. Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, T.-S. Yang has authored 12 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Hepatology. Recurrent topics in T.-S. Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). T.-S. Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Treatment and Pharmacology (3 papers). T.-S. Yang collaborates with scholars based in Taiwan, United States and China. T.-S. Yang's co-authors include Ian Wilcox, Ronald R. Grunstein, Jan Hedner, Pei‐Jer Chen, Tai-Jong Chao, Richard J. Epstein, Ann‐Lii Cheng, Chih‐Hung Hsu, Chiun Hsu and Han Chong Toh and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

T.-S. Yang

11 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T.-S. Yang Taiwan	7	222	212	162	123	121	12	543
Nada Tomanović Serbia	13	49 0.2×	34 0.2×	24 0.1×	38 0.3×	47 0.4×	43	472
Toshiaki Yoshimoto Japan	13	42 0.2×	37 0.2×	19 0.1×	123 1.0×	29 0.2×	79	454
Andrew J. Bryant United States	13	53 0.2×	18 0.1×	40 0.2×	255 2.1×	23 0.2×	34	483
Yoshitaka Iwazu Japan	11	91 0.4×	12 0.1×	36 0.2×	115 0.9×	63 0.5×	43	487
Stefan Wolter Germany	13	70 0.3×	47 0.2×	10 0.1×	46 0.4×	15 0.1×	37	490
K Thor Sweden	15	61 0.3×	9 0.0×	35 0.2×	167 1.4×	49 0.4×	32	1.2k
Stavros Anagnostoulis Greece	10	37 0.2×	15 0.1×	58 0.4×	56 0.5×	8 0.1×	18	333
F Matray France	9	21 0.1×	53 0.3×	19 0.1×	47 0.4×	14 0.1×	24	369
Emeline Lemarié France	11	116 0.5×	5 0.0×	70 0.4×	84 0.7×	11 0.1×	23	370

Countries citing papers authored by T.-S. Yang

Since Specialization

Citations

This map shows the geographic impact of T.-S. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T.-S. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T.-S. Yang more than expected).

Fields of papers citing papers by T.-S. Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T.-S. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T.-S. Yang. The network helps show where T.-S. Yang may publish in the future.

Co-authorship network of co-authors of T.-S. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of T.-S. Yang. A scholar is included among the top collaborators of T.-S. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T.-S. Yang. T.-S. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Li, Yangjun & T.-S. Yang. (2024). The effect of pre-operative biliary drainage in resectable periampullary lesions: a systematic review and meta-analysis. Cirugía y Cirujanos (English Edition). 92(3).

Yang, T.-S., et al.. (2023). Efficacy and Safety of TACE Combined with Lenvatinib and PD-(L)1 Inhibitor in the Treatment of Unresectable Hepatocellular Carcinoma: A Retrospective Study. Journal of Hepatocellular Carcinoma. Volume 10. 1435–1443. 9 indexed citations

Kelley, Robin Kate, Chris Verslype, Allen Lee Cohn, et al.. (2017). Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study. Annals of Oncology. 28(3). 528–534. 109 indexed citations

Cheng, Ann‐Lii, Gerardo Cornelio, Lin Shen, et al.. (2016). O-015 Association between depth of response (DpR) and survival outcomes in RAS-wild-type (wt) patients with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab once-every-2-weeks in the APEC study. Annals of Oncology. 27. ii123–ii123. 1 indexed citations

Hsu, Chih‐Hung, T.-S. Yang, Chiun Hsu, et al.. (2010). Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. British Journal of Cancer. 102(6). 981–986. 105 indexed citations

Yang, T.-S., Shenghui Qin, Won Young Tak, et al.. (2009). Impact of prior surgical resection with curative intent on the efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma (HCC): Subset analysis of the Asia-Pacific (AP) study. Journal of Clinical Oncology. 27(15_suppl). e15518–e15518. 1 indexed citations

Yang, T.-S., et al.. (2002). Gemcitabine and doxorubicin for the treatment of patients with advanced hepatocellular carcinoma: a phase I–II trial. Annals of Oncology. 13(11). 1771–1778. 44 indexed citations

Yang, T.-S.. (2002). Oral Uracil/Ftorafur (UFT) Plus Leucovorin as First-line Chemotherapy and Salvage Therapy with Weekly High-dose 5-Fluorouracil/Leucovorin for the Treatment of Metastatic Colorectal Cancer. Japanese Journal of Clinical Oncology. 32(9). 352–357. 7 indexed citations

Yang, T.-S.. (2001). Phase II Study of a Weekly 8-Hour 5-Fluorouracil and Leucovorin Infusion for Patients with Advanced Colorectal Cancer: Dose Adjusted According to its Toxicity. Japanese Journal of Clinical Oncology. 31(12). 610–615. 2 indexed citations

10.

Liau, Chi‐Ting, et al.. (1996). Intra-abdominal desmoplastic small cell tumors: report of two cases.. PubMed. 7(2). 228–32. 1 indexed citations

11.

Yang, T.-S., et al.. (1995). Regional skin blood flow in deep burn wounds: a preliminary report. Burns. 21(5). 340–343. 10 indexed citations

12.

Grunstein, Ronald R., et al.. (1993). Snoring and sleep apnoea in men: association with central obesity and hypertension.. PubMed. 17(9). 533–40. 254 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact